Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jujube syrup versus desloratadine for chronic urticaria
IRCT20220512054829N9Phase 3Recruiting
- Sponsor
- Kashan University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of desloratadine in chronic urticaria (CU) (2 arms), sponsored by Kashan University of Medical Sciences. Started Jun 2026; status: recruiting.
02
Drugs
desloratadine
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on IRCT20220512054829N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220512054829N9.